EGRX insider filings

EAGLE PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-01. Screen EGRX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EGRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — EAGLE PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2024-03-014Tarriff Scott — 10% ownerTax withholding (F): 2,119 @ $6.27EDGAR
2024-02-294Cahill Brian Joseph — CHIEF FINANCIAL OFFICERGrant/award (A): 3,800 @ $0 · Tax withholding (F): 1,589 @ $6.44EDGAR
2024-02-294Tarriff Scott — 10% ownerGrant/award (A): 12,950 · Tax withholding (F): 3,154 @ $6.44EDGAR
2024-02-064Cahill Brian Joseph — CHIEF FINANCIAL OFFICERTax withholding (F): 934 @ $5.85EDGAR
2024-01-094Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 735 @ $5.13EDGAR
2024-01-094Tarriff Scott — 10% ownerTax withholding (F): 4,322 @ $5.13EDGAR
2023-12-224Graves Michael — Interim Executive Chair & PEO, DirectorGrant/award (A): 293,000 (derivative) @ $0EDGAR
2023-12-204Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 452 @ $4.76EDGAR
2023-11-034Tarriff Scott — CEO, Director, 10% ownerSale (S): 10,925 @ $13.82 · Sale (S): 10,694 @ $13.87EDGAR
2023-10-314Graves Michael — DirectorOption exercise (M): 9,360 @ $4.94 · Option exercise (M): 9,360 (derivative) @ $0EDGAR
2023-10-044Tarriff Scott — CEO, Director, 10% ownerSale (S): 9,511 @ $15.23 · Sale (S): 10,024 @ $14.41 · Sale (S): 710 @ $15.11EDGAR
2023-05-184Tarriff Scott — CEO, Director, 10% ownerSale (S): 15,000 @ $19.98EDGAR
2023-05-154Tarriff Scott — CEO, Director, 10% ownerSale (S): 15,000 @ $20.71 · Sale (S): 3,131 @ $19.69 · Sale (S): 11,869 @ $20.42 · Sale (S): 14,800 @ $21.06 · Sale (S): 200 @ $21.52EDGAR
2023-03-094BORIO LUCIANA — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-094Edlin Richard A. — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-094Glenning Robert — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-094Simpson Jennifer K. — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-094Graves Michael — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-094RATOFF STEVEN B — DirectorGrant/award (A): 16,253 (derivative) @ $0EDGAR
2023-03-024Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 718 @ $28 · Grant/award (A): 18,500 @ $0EDGAR
2023-03-024Tarriff Scott — CEO, Director, 10% ownerTax withholding (F): 3,113 @ $28 · Grant/award (A): 70,900 @ $0EDGAR
2023-02-064Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 785 @ $34.09EDGAR
2023-01-314Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 601 @ $33.21EDGAR
2023-01-244Tarriff Scott — CEO, Director, 10% ownerTax withholding (F): 3,732 @ $33.64EDGAR
2023-01-094Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 734 @ $29.26EDGAR
2023-01-094Tarriff Scott — CEO, Director, 10% ownerTax withholding (F): 3,827 @ $29.26EDGAR
2022-12-214Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 461 @ $30.03EDGAR
2022-09-084Edlin Richard A. — DirectorSale (S): 6,800 @ $30.99EDGAR
2022-03-024Moran Michael Shawn — EVP, Chief Commercial OfficerGrant/award (A): 10,400 @ $0EDGAR
2022-03-024BORIO LUCIANA — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-03-024Cahill Brian Joseph — Chief Financial OfficerGrant/award (A): 8,000 @ $0EDGAR
2022-03-024Edlin Richard A. — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-03-024Glenning Robert — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-03-024Simpson Jennifer K. — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-03-024Tarriff Scott — CEO, Director, 10% ownerGrant/award (A): 34,800 @ $0EDGAR
2022-03-024Graves Michael — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-03-024RATOFF STEVEN B — DirectorGrant/award (A): 11,200 (derivative) @ $0EDGAR
2022-02-044Moran Michael Shawn — EVP, Chief Commercial OfficerTax withholding (F): 742 @ $45.03EDGAR
2022-02-044Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 805 @ $45.03EDGAR
2022-02-014Moran Michael Shawn — EVP, Chief Commercial OfficerTax withholding (F): 210 @ $45.94EDGAR
2022-02-014Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 626 @ $45.94EDGAR
2022-01-114Moran Michael Shawn — EVP, Chief Commercial OfficerTax withholding (F): 90 @ $50.63EDGAR
2022-01-114Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 263 @ $50.63EDGAR
2022-01-074Moran Michael Shawn — EVP, Chief Commercial OfficerTax withholding (F): 1,511 @ $50.69EDGAR
2022-01-074Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 738 @ $50.69EDGAR
2021-12-214Cahill Brian Joseph — Chief Financial OfficerTax withholding (F): 467 @ $55.42EDGAR
2021-04-304BORIO LUCIANA — DirectorGrant/award (A): 13,500 (derivative) @ $0EDGAR
2021-04-124RATOFF STEVEN B — DirectorOption exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 @ $4.42 · Option exercise (M): 2,340 (derivative) @ $0 · Option exercise (M): 2,340 (derivative) @ $0 · Option exercise (M): 2,340 (derivative) @ $0EDGAR
2021-04-074RATOFF STEVEN B — DirectorOption exercise (M): 2,340 @ $8.78 · Option exercise (M): 2,340 (derivative) @ $0EDGAR
2021-04-054Tarriff Scott — CEO, Director, 10% ownerGift (G): 16,340 @ $0 · Option exercise (M): 31,201 @ $8.78 · Tax withholding (F): 16,278 @ $41.87 · Option exercise (M): 31,201 (derivative) @ $0EDGAR

Recent 8-K events — EAGLE PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-12-028-K1.01 — Entry into a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-278-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-158-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-318-K1.01 — Entry into a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-028-K2.02 — Results of Operations and Financial Condition
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8.01 — Other Events
EDGAR
2024-08-278-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-058-K8.01 — Other EventsEDGAR
2024-07-108-K1.01 — Entry into a Material Definitive AgreementEDGAR
2024-05-298-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EGRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs